Session » (2052–2078) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Date: Tuesday, October 28, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 2054

A Changing Paradigm: Reassessing the Role of Muscle Biopsy in Idiopathic Inflammatory Myopathies in a Single-Center Cohort

10:30AM-12:30PM: Abstract Number: 2053

A Prospective Study Unveils Damage Accrual and Myositis Specific Antibodies as Key Risk Factors for Mortality in Myositis

10:30AM-12:30PM: Abstract Number: 2059

Autoantibody Patterns in Myositis Immunoblot Testing: A Retrospective Study inInflammatory Myopathies and Connective Tissue Diseases (2017–2023)

10:30AM-12:30PM: Abstract Number: 2073

Cell-free DNA as a Potential Marker of Muscle Involvement and Treatment Response in Myositis

10:30AM-12:30PM: Abstract Number: 2070

Characterization of Hospitalization, Patient Demographics and Impact of Idiopathic Inflammatory Myopathies on Hospitalization Outcomes in Adult Fracture Patients: A National Inpatient Sample Analysis.

10:30AM-12:30PM: Abstract Number: 2057

Clinical Associations of Anti-Ro52 Antibodies in Idiopathic Inflammatory Myopathies: A Scoping Review

10:30AM-12:30PM: Abstract Number: 2068

Comparing characteristics, diagnostics, and treatment in people with different idiopathic inflammatory myopathies using a large representative cohort

10:30AM-12:30PM: Abstract Number: 2069

Concordance of low titer positive myositis-specific autoantibodies and myositis-associated autoantibodies on subsequent myositis panel testing.

10:30AM-12:30PM: Abstract Number: 2055

Construct Validity of Total Improvement Score (TIS) as an Endpoint for Clinically Meaningful Improvement in Multiple Patient-Centered Outcome Measures in Dermatomyositis

10:30AM-12:30PM: Abstract Number: 2075

Ferritin trends differentiate anti-MDA5 Dermatomyositis from anti-Jo1 Antisynthetase Syndrome

10:30AM-12:30PM: Abstract Number: 2062

Immune Cell Signatures Associated with Disease Activity in Dermatomyositis Across Autoantibody Subtypes

10:30AM-12:30PM: Abstract Number: 2071

Impact of Diagnostic Delay on Disease Activity and Cumulative Damage in Patients with Idiopathic Inflammatory Myopathies in a Third-level Hospital in Mexico

10:30AM-12:30PM: Abstract Number: 2074

Increased Mortality in Hispanic Males with Lymphopenia: A Descriptive and Statistical Analysis of Anti-Melanoma Differentiation-Associated Protein 5 (MDA-5) Antibody Positive Patients

10:30AM-12:30PM: Abstract Number: 2064

Kinematics Underlying IBM-induced Dysphagia

10:30AM-12:30PM: Abstract Number: 2063

Linking PROMIS scores to disease severity and treatment in dermatomyositis: a patient-centered evaluation

10:30AM-12:30PM: Abstract Number: 2078

Neutrophil Extracellular Traps from Patients with Idiopathic Inflammatory Myopathies Induce Interferogenic Responses in Macrophages and Myeloid Dendritic Cells

10:30AM-12:30PM: Abstract Number: 2076

Nutritional Discourse in Online Myositis Communities: A Reddit Analysis of Patient-led Discussions

10:30AM-12:30PM: Abstract Number: 2058

Organ-specific disease activity and serological patterns in idiopathic inflammatory myopathies: A descriptive study in a Hispanic cohort

10:30AM-12:30PM: Abstract Number: 2065

Pain in Idiopathic Inflammatory Myopathies: A Global Study of Patient Experience

10:30AM-12:30PM: Abstract Number: 2067

Patterns of Comorbidity in Idiopathic Inflammatory Myopathies: A Cross-sectional Analysis of Disease Burden and Risk Factors

10:30AM-12:30PM: Abstract Number: 2052

Prevalence of anti-neutrophil extracellular trap antibodies and their relationship with the clinical characteristics of patients with idiopathic inflammatory myopathies.

10:30AM-12:30PM: Abstract Number: 2066

Psychosocial Factors Strongly Influence Subjective Well-being in Patients with Idiopathic Inflammatory Myopathies

10:30AM-12:30PM: Abstract Number: 2072

Results of an Integrated Program for Early Cancer Detection in Idiopathic Inflammatory Myopathies

10:30AM-12:30PM: Abstract Number: 2077

Statin-Associated Immune-Mediated Necrotizing Myopathy in Native Americans

10:30AM-12:30PM: Abstract Number: 2056

Systematic Review: Nutritional Interventions in Muscle Diseases

10:30AM-12:30PM: Abstract Number: 2060

Treatment Patterns And Drug Use In Idiopathic Inflammatory Myopathies. Description Of The First Year After Diagnosis In A Swedish Myositis Cohort.

10:30AM-12:30PM: Abstract Number: 2061

Tryptophan Metabolism Alteration Is Associated With Rapidly Progressive Interstitial Lung Disease Of Anti-MDA5+ Dermatomyositis

« View all sessions from this meeting